Abstract:Background: Antimicrobial stewardship programs, particularly pharmacist-driven programs, help reduce the unnecessary use of antimicrobial agents. The objective of this study was to assess the influence of pharmacist-driven antimicrobial stewardship on antimicrobial use, multidrug resistance, and patient outcomes in adult intensive care units in China.Method: We conducted a multicenter prospective cohort study with a sample of 577 patients. A total of 353 patients were included under a pharmacist-driven antimicrobial stewardship program, whereas the remaining 224 patients served as controls. The primary outcome was all-cause hospital mortality.Results: The pharmacist-driven antimicrobial stewardship program had a lower hospital mortality rate compared with the nonpharmacist program (19.3% vs 29.0%; P =.007). Furthermore, logistic regression analysis indicated that the pharmacist-driven program independently predicted hospital mortality (odds ratio, 0.57; 95% confidence interval, 0.36-0.91; P =.017) after adjustment. Meanwhile, this strategy had a lower rate of multidrug resistance (23.8% vs 31.7%; P =.037). Moreover, the strategy optimized antimicrobial use, such as having a shorter duration of empirical antimicrobial therapy (2.7 days; interquartile range [IQR], 1.7-4.6 vs 3.0; IQR, 1.9-6.2; P =.002) and accumulated duration of antimicrobial treatment (4.0; IQR, 2.0-7.0 vs 5.0; IQR, 3.0-9.5; P =.030).Conclusions: Pharmacist-driven antimicrobial stewardship in an intensive care unit decreased patient mortality and the emergence of multidrug resistance, and optimized antimicrobial agent use. (C) 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Case report of clinical pharmacist participating in the treatment of urinary tract infection

Case report of clinical pharmacist participating in the treatment of acute pyelonephritis patient with repeated fever

Case report of clinical pharmacists participating in the treatment of Pseudomonas aeruginosa pneumonia with chronic renal failure

The Pharmaceutical Care of a Patient with Complicated Urinary Tract Infection Caused by Enterococcus Faecium

Work Experience Sharing and Case Studies of Clinical Pharmacy

Clinical pharmacists involvement in consultation：analysis and experience of 141 cases of infectious disease

Clinical Pharmacist Participating in Anti-infective Treatment for a Patient with Post-surgery Infection

Medication analysis and pharmaceutical care for a Parkinson′s disease patient with mental disorders

The Pharmaceutical Care on the Infected Patients after Trauma by Clinical Pharmacists

Pharmaceutical Care for One Patient with Drug-induced Liver Failure Complicated with Pulmonary Infection by Clinical Pharmacists

Analysis and monitoring of drug therapy in a patient with peptic ulcer complicated by infection: A case report

[Pharmaceutical Care of Patient with Cryptococcal Meningitis: a Case Report].

Pharmaceutical Practice for Anti-infection Treatment Optimization in Treatment of Liver Abscess by Pharmacists

Analysis of Clinical Pharmacist Participating in the Treatment for a Patient with Skin Soft-tissue Infection

Case analysis of postoperative anti -infection consultation with surgical clinical pharmacists′participation

Case report on mental disorder associated with combination imipenem-cilastatin and methylprednisolone

Pharmaceutical care for one case of patient with hypertension complicated with the cardiac, lung and renal insufifciency

Experience of Clinical Pharmacists' Participation in the Drug Treatment of Foot G+ Gross Coli Mixed G-Bacillus Infections

Pharmaceutical Care for a Patient with Diabetic Feet Combining Coronary Artery Disease:a Case Report

Pharmacist-driven Antimicrobial Stewardship in Intensive Care Units in East China: A Multicenter Prospective Cohort Study

Analysis of Antibiotics Use in One Case of Community-acquired Pseudomonas aeruginosa Lung Abscess